Digital Health Startups

KinergyCare provides chronic care management (CCM) solutions for healthcare providers, combining technology with personalized care coordination services.

1 investor

ProAxsis provides biomarker analysis services and research assays for respiratory disease drug development, serving pharmaceutical, biotechnology, and academic research organizations.

1 investor

Probari provides clinical care management and operational support for nursing homes and long-term care facilities. The company delivers data analytics, clinical oversight, and operational infrastructure to reduce hospitalizations and improve quality measures in post-acute care settings.

1 investor

ProblemShared is an online mental health and neurodevelopmental platform offering remote assessments for ADHD, autism, and specific learning differences, alongside post-diagnostic services including therapy, medication prescribing, and psychoeducation for individuals and institutional partners like NHS trusts and universities in the UK.

1 investor

ProciseDx develops diagnostic technology, including a point-of-care testing platform, drawing on expertise in central lab instrumentation and point-of-care devices. It serves the point-of-care diagnostics market.

1 investor

Profionics develops host-response biomarker technology for rapid detection and diagnosis of sepsis. The company serves healthcare providers and operates in the diagnostic and biotech sectors.

1 investor

Progentec develops diagnostic and digital health solutions for autoimmune disease detection and treatment, including biomarker tests and remote monitoring technologies for clinicians and patients. The company focuses on improving health outcomes for the 25 million Americans living with autoimmune diseases.

1 investor

ProgenyHealth provides personalized maternity and neonatal intensive care management for health plan members, spanning prenatal care through 12 months postpartum. The company serves payers and physicians with integrated case management, NICU utilization oversight, and claims review services to improve maternal and infant health outcomes while reducing unnecessary healthcare costs.

1 investor

indi is an AI-powered app that helps parents of children with additional or special needs manage their care journey by organizing records, assessments and appointments, tracking progress, and keeping therapists, educators and family in sync. It is also adopted by paediatric clinics to coordinate care across caseloads.

1 investor

Lumos is building a foundation model of human physiology that learns from raw physiological signals to improve medical diagnosis and drug development. The company trains multimodal, continuous-time models on full-resolution physiological data streams to unlock insights that current medicine discards.

1 investor

Project M is a healthcare platform that uses AI and causal inference to optimize care strategies for individual patients, providing real-time, evidence-based treatment recommendations along with cost and outcome implications. It targets clinical and administrative decision-making to support value-based care, with an initial validated use case in hip fracture treatment and alignment to CMS incentive programs such as TEAM.

1 investor

Prolight Diagnostics develops the Psyros platform, a point-of-care diagnostic system designed to deliver laboratory-quality test results at the patient bedside with speed and cost-effectiveness. The company serves clinical diagnostics markets including traumatic brain injury and cardiac biomarkers.

1 investor

Prometheus Laboratories is a specialty clinical laboratory that discovers, develops, and commercializes diagnostic testing services for Inflammatory Bowel Disease and other gastrointestinal disorders. Its tests help clinicians with disease stratification, therapy selection, treatment optimization, and monitoring across the patient journey.

1 investor

Promptly is a patient experience and engagement software suite for specialty medical practices, offering tools to automate practice operations and appointment scheduling. Its team includes developers who have built EHR and practice management systems, and it focuses on improving care workflows and patient connection.

1 investor

A mobile app that lets users get consultations about skin moles and potential melanoma, directing them to oncologists for further examination. It is used by consumers to help detect skin cancer early.

1 investor

ProSomnus offers oral appliance devices for treating obstructive sleep apnea and snoring, positioned as an alternative to CPAP machines. The company targets adults with sleep apnea seeking to reduce health risks such as stroke and cardiovascular disease.

1 investor

PROSPERiA is a healthtech company that uses artificial intelligence and clinical expertise to develop early detection tools for preventive diagnostics, operating primarily in Mexico and Latin America to expand access to high-quality healthcare in emerging markets.

1 investor

Prosper Infusion delivers home-based intravenous infusion therapy and specialty pharmacy services to patients with complex chronic and rare diseases. The company coordinates medical, pharmacy, and nursing care with a focus on value-based outcomes and cost reduction.

1 investor

Prota Therapeutics is a late clinical-stage biotech company developing allergen oral immunotherapies to treat food allergies, with a lead phase-3-ready product (PRT120) targeting peanut allergy. Its technology originated from research led by Professor Mimi Tang at the Murdoch Children's Research Institute in Melbourne, Australia.

1 investor

PROTECT3D makes patient-specific 3D-printed braces, splints, orthotics, and protective facemasks created from a smartphone (iPhone) anatomy scan and manufactured in an FDA-certified facility. It serves patients, healthcare providers, and sports teams, including NCAA, NFL, and professional organizations, across foot & ankle, hand & wrist, and sports medicine use cases in the US.

1 investor

ProteomEdge develops mass spectrometry-based analytical platforms and proprietary heavy-labelled protein standard panels for absolute protein quantification in blood plasma, targeting clinically relevant biomarkers such as apolipoproteins, complement factors, and liver disease markers. Its products serve research and translational proteomics customers, including academic core facilities and precision medicine researchers. Based in Stockholm, Sweden.

1 investor

Proto is an AI-native electronic medical record (EMR) system designed for direct-to-patient care. It targets healthcare providers operating direct patient care models.

1 investor

Protyon develops personalized cancer therapies using computational modeling expertise. The company serves cancer patients and researchers in the biotech and healthcare industry.

1 investor

Proud Moments is a provider of applied behavior analysis (ABA) therapy for children diagnosed with autism, delivering clinical care through licensed BCBAs and behavioral therapists.

1 investor